Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
10.1161/CIRCRESAHA.110.223818 31 SharmaV.DhillonP.ParsonsH.AllardM
Injectable Wegovy can be used in a wider population, with approval for use in patients 12 years of age and older for weight loss, and an additional indication for metabolic dysfunction-associated steatohepatitis (MASH) in adults
Marsh, M
Minor skin changes often improve over time, but significant laxity may require surgical correction
According to the Cleveland Clinic, excess body weight is a risk factor for OSA because it increases the volume of tissue that can press down on the windpipe during sleep
However, the product's lack of quality assurances, like third-party testing, was a major downside
